CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 38 enrolled
Drug / intervention
CCOCP +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00517556
NCT00517556Phase 2Completed
CompareCT.gov

Continuous Administration of a Monophasic Oral Contraceptive in the Treatment of Primary Dysmenorrhea

Milton S. Hershey Medical Center·interventional·Posted Aug 17, 2007·Updated Apr 28, 2017

In Brief

A Phase 2 clinical trial evaluating CCOCP and Traditional OCP for Dysmenorrhea. Completed, enrolled 38 participants across 1 site.

Detailed Summary

The primary hypothesis is that continuous administration of an OCP (CCOCP regimen) will result in more pain relief than a traditional 21/7 administration in primary dysmenorrhea (PD) patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDysmenorrhea
CountriesCroatia
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 17, 2007
Enrollment StartAug 1, 2007
Primary CompletionMar 1, 2011
Study CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 18.9 years ago

Interventions

CCOCPdrug

(CCOCP) continuous treatment with Monophasic oral gestodene/ethinyl estradiol

Traditional OCPdrug

(traditional OCP) (21 active days/7 inactive days) treatment regimen